Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Deletion of naïve T cells recognizing the minor histocompatibility antigen HY with toxin-coupled peptide-MHC class I tetramers inhibits cognate CTL responses and alters immunodominance.

Hess SM, Young EF, Miller KR, Vincent BG, Buntzman AS, Collins EJ, Frelinger JA, Hess PR.

Transpl Immunol. 2013 Dec;29(1-4):138-45. doi: 10.1016/j.trim.2013.10.005. Epub 2013 Oct 23.

2.

Identification of the immunodominant HY H2-D(k) epitope and evaluation of the role of direct and indirect antigen presentation in HY responses.

Millrain M, Scott D, Addey C, Dewchand H, Ellis P, Ehrmann I, Mitchell M, Burgoyne P, Simpson E, Dyson J.

J Immunol. 2005 Dec 1;175(11):7209-17.

3.
4.

Antigen-specific modulation of an immune response by in vivo administration of soluble MHC class I tetramers.

Maile R, Wang B, Schooler W, Meyer A, Collins EJ, Frelinger JA.

J Immunol. 2001 Oct 1;167(7):3708-14.

5.

Quantitative analysis of the immune response to mouse non-MHC transplantation antigens in vivo: the H60 histocompatibility antigen dominates over all others.

Choi EY, Yoshimura Y, Christianson GJ, Sproule TJ, Malarkannan S, Shastri N, Joyce S, Roopenian DC.

J Immunol. 2001 Apr 1;166(7):4370-9.

6.

Peripheral "CD8 tuning" dynamically modulates the size and responsiveness of an antigen-specific T cell pool in vivo.

Maile R, Siler CA, Kerry SE, Midkiff KE, Collins EJ, Frelinger JA.

J Immunol. 2005 Jan 15;174(2):619-27.

8.

Examination of HY response: T cell expansion, immunodominance, and cross-priming revealed by HY tetramer analysis.

Millrain M, Chandler P, Dazzi F, Scott D, Simpson E, Dyson PJ.

J Immunol. 2001 Oct 1;167(7):3756-64.

9.

Tetramer-blocking assay for defining antigen-specific cytotoxic T lymphocytes using peptide-MHC tetramer.

Yokouchi H, Chamoto K, Wakita D, Noguchi D, Yamazaki K, Dosaka-Akita H, Nishimura M, Ikeda H, Nishimura T.

Cancer Sci. 2006 Feb;97(2):148-54.

10.

Modulation of CD8+ T cell response to antigen by the levels of self MHC class I.

Santori FR, Arsov I, Vukmanović S.

J Immunol. 2001 May 1;166(9):5416-21.

11.

Few peptides dominate cytotoxic T lymphocyte responses to single and multiple minor histocompatibility antigens.

Yin L, Poirier G, Neth O, Hsuan JJ, Totty NF, Stauss HJ.

Int Immunol. 1993 Sep;5(9):1003-9.

PMID:
7694638
12.
13.

Minor antigen distribution predicts site-specific graft-versus-tumor activity of adoptively transferred, minor antigen-specific CD8 T Cells.

Shand JC, Qin H, Nasholm N, Capitini CM, Fry TJ.

Biol Blood Marrow Transplant. 2014 Jan;20(1):26-36. doi: 10.1016/j.bbmt.2013.10.009. Epub 2013 Oct 17.

14.

Direct evidence for in vivo induction of CD8+ cytotoxic T cells directed to donor MHC class I peptides following mouse allotransplantation.

Popov IA, Fedoseyeva EV, Orr PL, Garovoy MR, Benichou G.

Transplantation. 1995 Dec 27;60(12):1621-4.

PMID:
8545902
15.
17.

Effective graft depletion of MiHAg T-cell specificities and consequences for graft-versus-host disease.

de Witte MA, Toebes M, Song JY, Wolkers MC, Schumacher TN.

Blood. 2007 May 1;109(9):3830-8. Epub 2007 Jan 3.

18.

On the mechanisms of immunodominance in cytotoxic T lymphocyte responses to minor histocompatibility antigens.

Pion S, Fontaine P, Desaulniers M, Jutras J, Filep JG, Perreault C.

Eur J Immunol. 1997 Feb;27(2):421-30.

PMID:
9045913
19.

Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes.

Gallimore A, Glithero A, Godkin A, Tissot AC, Plückthun A, Elliott T, Hengartner H, Zinkernagel R.

J Exp Med. 1998 May 4;187(9):1383-93.

20.

Generation of cytotoxic T lymphocytes by MHC class I ligands fused to heat shock cognate protein 70.

Udono H, Yamano T, Kawabata Y, Ueda M, Yui K.

Int Immunol. 2001 Oct;13(10):1233-42.

PMID:
11581168

Supplemental Content

Support Center